Prostate cancer remains one of the most prevalent cancers among men worldwide. For patients with advanced or metastatic prostate cancer, innovative treatments such as targeted radioligand therapies (RLT) are offering new hope. These therapies combine the precision of molecular targeting with the effectiveness of radiotherapy, providing tailored solutions for patients who may not respond to conventional treatments.
Understanding Radioligand Therapy (RLT)
Radioligand therapy involves using radioactive isotopes attached to ligands—molecules
